Want to join the conversation?
$PPL reaffirmed its 2016 EPS from ongoing operations guidance of $2.25-2.45 and EPS outlook of $2.29-2.49. The company also reaffirmed its expectation that it will achieve compound annual growth through 2018 of 5-6% off of 2014 EPS from ongoing operations of $2.03.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.